Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial.

Autor: Kwon H; Immunology Laboratory, Cancer Genomic Research Institute, Seoul Song Do Colorectal Hospital, Seoul, 04597, Republic of Korea., Nam EH; Department of Microbiology, College of Medicine, Inha University, Incheon, 22212, Republic of Korea.; Department of Biomedical Science, Program in Biomedical Science and Engineering, Inha University, Incheon, 22212, Republic of Korea., Kim H; Ildong Bioscience, Pyeongtaek-si, Gyeonggi-do, 17957, Republic of Korea., Jo H; Department of Microbiology, College of Medicine, Inha University, Incheon, 22212, Republic of Korea.; Department of Biomedical Science, Program in Biomedical Science and Engineering, Inha University, Incheon, 22212, Republic of Korea., Bang WY; Ildong Bioscience, Pyeongtaek-si, Gyeonggi-do, 17957, Republic of Korea., Lee M; Ildong Bioscience, Pyeongtaek-si, Gyeonggi-do, 17957, Republic of Korea., Shin H; Immunology Laboratory, Cancer Genomic Research Institute, Seoul Song Do Colorectal Hospital, Seoul, 04597, Republic of Korea., Kim D; Immunology Laboratory, Cancer Genomic Research Institute, Seoul Song Do Colorectal Hospital, Seoul, 04597, Republic of Korea., Kim J; Digestive Endoscopic Center, Seoul Song Do Colorectal Hospital, Seoul, 04597, Republic of Korea., Kim H; Digestive Endoscopic Center, Seoul Song Do Colorectal Hospital, Seoul, 04597, Republic of Korea., Lee J; Department of Surgery, Pelvic Floor Center, Seoul Song Do Colorectal Hospital, Seoul, 04597, Republic of Korea., Jung YH; School of Food Science and Biotechnology, Kyungpook National University, Daegu, 41566, Republic of Korea.; Institute of Fermentation Biotechnology, Kyungpook National University, Daegu, 41566, Republic of Korea., Yang J; Department of Microbiology, Dongguk University College of Medicine, 123 Dongdae-ro, Gyeongju, 38066, Republic of Korea. dbl3jwy@dongguk.ac.kr., Won DD; Department of Surgery, Pelvic Floor Center, Seoul Song Do Colorectal Hospital, Seoul, 04597, Republic of Korea. greatsongdo@gmail.com., Shin M; Department of Microbiology, College of Medicine, Inha University, Incheon, 22212, Republic of Korea. mhshin@inha.ac.kr.; Department of Biomedical Science, Program in Biomedical Science and Engineering, Inha University, Incheon, 22212, Republic of Korea. mhshin@inha.ac.kr.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2024 Sep 27; Vol. 14 (1), pp. 22384. Date of Electronic Publication: 2024 Sep 27.
DOI: 10.1038/s41598-024-72887-x
Abstrakt: Irritable bowel syndrome is a chronic disorder affecting the gastrointestinal tract, negatively impacting patients' quality of life. Here, we aimed to evaluate the effects of Lacticaseibacillus rhamnosus IDCC 3201 (RH 3201) on irritable bowel syndrome with constipation (IBS-C). In this randomised, double-blind, placebo-controlled trial, a total of 30 subjects with IBS-C were randomly assigned (1:1) to receive 8 weeks of probiotics administration or placebo. Concerning bowel activities, both irritant bowel movements and discomfort caused by constipation showed significant improvement with RH 3201 at 8 weeks. Symptoms including severity of abdominal bloating, frequency of abdominal bloating, and satisfaction of bowel habits based on the irritable bowel syndrome-severity scoring system also ameliorated in the probiotic group. Analysis of the fecal microbiome revealed that the abundance of Bacteroides cellulosilyticus and Akkermansia muciniphila was higher during the period of RH 3201 administration compared to the placebo. Untargeted metabolome analysis further suggested a correlation between specific metabolites, such as N-acetylornithine, xanthine, and 3-phenylpropionic acid, and the improvement of clinical symptoms. These results indicate that RH 3201 was effective in ameliorating IBS-C, potentially by enriching beneficial microbes and associated metabolites in the gut environment.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: